Abstract
Esophageal superficial cancers with negligible risk for lymph node metastasis can be cured by endoscopic local resection. Endoscopic mucosal resection (EMR) is a conventional technique, which can resect relatively small lesion by using a snare. On the contrary, endoscopic submucosal dissection (ESD) can resect superficial lesion in an en bloc fashion irrespective of the size or presence of submucosal fibrosis, which has made the indication of endoscopic resection expanded. Although skillful hands in endoscopy and sufficient knowledge of possible complications are required, ESD is a promising technique as a minimally invasive treatment.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
14.1 Introduction
Due to improvement of therapeutic endoscopy in recent years such as ESD, size limitation of a resectable extent by endoscopy has disappeared. In a so-called “pre-ESD” era, EMR using an electrocautery snare was one and only available technique. This technique, however, could be applied only to small mucosal lesions because of the limitation in size. In case of large lesions, piecemeal resection is unavoidable, which may make histological evaluation difficult and even inaccurate [1, 2]. Development of ESD has changed the indication of endoscopic resection, owing to the unique characteristics of this technique. That is, ESD has technically enabled early gastrointestinal cancers to be resected endoscopically in an en bloc fashion irrespective of the size or presence of submucosal fibrosis [3, 4]. Indication and methods of each technique as well as management of complications are summarized in this chapter.
14.2 Indication of Endoscopic Resection
According to the Japanese Classification of Esophageal Cancer, superficial carcinoma of the esophagus is defined as one invading up to the submucosa [5]. Among them, superficial carcinoma confined to the mucosa is called early cancer of the esophagus. Indication of endoscopic resection is determined mainly by the risk of lymph node metastasis [5–9]. If early cancer invading up to lamina propria mucosae (T1a-EP or LPM), where the risk of lymph node metastasis is thought to be less than 5 % [5], is resected completely, curative resection will be expected. Therefore, T1a-EP and LPM are accepted as an absolute indication of endoscopic resection. Meanwhile, superficial cancer invading to muscularis mucosae (MM) or superficial submucosa up to 200 μm (SM1) has 10–15 % of the risk of lymph node metastasis [8]. However, other treatment options for esophageal cancer, e.g., chemoradiotherapy or surgery, are generally more invasive and also inhere considerable risks for major complications; therefore endoscopic local resection for such cancers is acceptable as a relative indication. Obviously, negative lymphovascular infiltration should be confirmed histologically after complete resection of the tumor, to be judged as curative in both conditions.
On the other hand, extensive resection of the mucosa could be accompanied with severe stricture after treatment, which causes feeding disorder and consequently loses the quality of life of the patients seriously [10, 11]. Although endoscopic balloon dilatation can avoid surgical intervention, frequent dilatation and a risk of perforation during dilatation must be a burden for the patients [12, 13]. In this reason, general indication of endoscopic resection for lateral tumor extension is up to three-fourths of circumference. However, complete circumferential resection can be available as a relative indication if the patient accepts the risk for severe stricture and this additional troublesome endoscopic treatment.
14.3 Endoscopic Mucosal Resection (EMR)
EMR is composed of fluid injection into the submucosa and mucosal resection with part of the submucosa using an electrocautery snare. There are some technical variations in EMR (Fig. 14.1).
EMR with a ligation device (EMR-L) requires an O-ring used for esophageal varices ligation (Fig. 14.1a) [14]. In this technique, after suctioning a lesion and ligating it with the O-ring to create a pseudopolyp, endoscopic resection is performed just below the O-ring using a snare. Although submucosal injection before the resection is conventionally desirable in order to avoid unexpected perforation, endoscopic resection using a ligation device without submucosal injection seems to be also acceptable especially for early Barrett’s neoplasia [15].
In EMR using a cap-fitted endoscope (EMR-C), a transparent hood attached to the tip of the endoscope is used (Fig. 14.1b) [16]. After opening a semilunar snare along the rim of the hood, an elevated lesion by submucosal injection is suctioned into the hood and resected by the snare. In this technique, setting the snare along the rim of the hood can be difficult and time-consuming that it sometimes makes the operator irritated.
In endoscopic esophageal mucosal resection (EEMR)-tube method, a long transparent silicon overtube is used (Fig. 14.1c) [17]. After submucosal injection, the lesion is suctioned by the overtube introduced over the endoscope and tightened by a snare preliminarily introduced through the side channel of the overtube. Resection should be done after confirming that the muscular layer is not involved because a diameter of the overtube is much larger than any other EMR caps.
A grasping and pulling technique using a two-channel endoscope is called two-channel EMR method (Fig. 14.1d) [18]. A grasping forceps from one working channel is passed through a snare introduced from the other channel. The elevated lesion by submucosal injection is grasped with the forceps and tightened with the snare at the bottom of the grasped mucosa. Again, resection should be done after confirming that the muscular layer is not involved within the ligated tissue.
Because the size of snares is limited in these EMRs, available size of en bloc resection is also limited [3, 4, 19, 20]. Expected maximal size of one specimen is thought to be approximately 2 cm. Besides, the resectable size is also limited by the diameter of the O-ring in EMR-L, the hood in EMR-C, and the overtube in EEMR-tube. Furthermore, in case of having severe fibrosis under the lesion, it usually becomes quite difficult to resect the lesion by these EMRs because a snare is easily slipped from the target. Accordingly, early esophageal cancer 1 cm or less without fibrosis would be suitable for a candidate of EMR in usual clinical settings.
14.4 Endoscopic Submucosal Dissection (ESD)
This epoch-making technique is composed of four steps: marking around the lesion after chromoendoscopy, submucosal injection, circumferential mucosal incision, and dissection of the submucosal connective tissue (Fig. 14.2). Because the operator can determine the extent of resection and dissect the submucosal tissue under the direct vision, ESD can offer reliable en bloc, margin-free resection irrespective of the size or presence of submucosal fibrosis.
14.4.1 Details of Practical Skill
Among various electrocautery knives specialized for ESD, pointed tip-type knives would be suitable especially for esophageal ESD due to the narrow lumen and the thin wall of the esophagus (Fig. 14.3) [21–23].
Successful resection requires accurate endoscopic diagnosis of a tumor extent. Although promising image-enhancement endoscopy techniques have been introduced, conventional chromoendoscopy using iodine spraying would be still most useful in determining the extent of the lesion. Using a tip of the knife, markings are made 2–3 mm outside the lesion at intervals of approximately 3 mm.
In creating a submucosal fluid cushion, an injection needle is gently advanced into the submucosa at the outside of markings, and a fluid colored with a small amount of indigo carmine, which is helpful to visualize the submucosa, is injected into the submucosa to make sufficient submucosal space for incision and dissection. Hypertonic or viscous injection fluid such as Glyceol™ (Chugai Pharmaceutical Co., Japan; consisted of 10 % glycerine, 5 % fructose, and 0.9 % sodium chloride) or hyaluronic acid solution is desirable for long-lasting submucosal cushion. Injection directly through the cancerous area should be avoided in order to prevent cancer cell implantation in the deeper layer.
The mucosa 1–2 mm outside of markings is usually cut with cutting current using specific knife. Right after partial mucosal incision, initial submucosal dissection should be made along the incision line with coagulation current. To make sure the end point of submucosal dissection, it is better to cut the anal side of the lesion first and subsequently continue the procedure from the oral side.
It is very important to conduct submucosal dissection under direct vision using transparent hood. The knife should be moved parallel to the plane of the muscular layer during submucosal dissection to avoid muscular injury or perforation. Repeat submucosal injection, mucosal incision, and submucosal dissection step by step until end of the procedure.
14.5 Management of Complications
14.5.1 Bleeding
Unlike gastric ESD, the rate of postoperative bleeding is relatively low (0–2 %) [24–27]. In case of minor bleeding, hemostasis using the retracted tip of the knife is firstly attempted. When it is difficult to stop bleeding or it bleeds massively, hemostatic forceps should be used. After the retrieval of the resected specimen, the resection wound should be carefully inspected to check for visible vessels. And every thick exposed blood vessels should be coagulated, avoiding excessive thermal damage.
14.5.2 Perforation
Perforation should be paid more attention especially in esophageal ESD. Because the esophagus has no serosa, exposure of the muscular layer may cause pneumomediastinum [28, 29]. Indeed, pneumomediastinum was found by CT scan in a half of treated cases after esophageal ESD, although fortunately these were almost subclinical [28]. Damage of the muscular layer might lead to delayed perforation, which could become fatal mediastinitis. Therefore, it is necessary to follow up the patient carefully, especially after perforation, muscular injury, and severe thermal damage. In case of perforation, patients are treated at rest with fasting and administered antibiotics until a fever and inflammation are relieved. Generally, emergency endoscopy for the purpose of detection and closure of a perforation site is not indicated because it may be not only ineffective but also a cause of spread of mediastinitis.
14.5.3 Postoperative Stricture
The risk of postoperative stricture is particularly higher in esophageal ESD (Fig. 14.4) [10, 11]. Because the probability of stricture mostly depends on the resected size, a lesion over three-fourths of circumference is relative indication of ESD as previously mentioned. Several attempts to prevent postoperative stricture have been tried [30–35], e.g., prophylactic endoscopic balloon dilatation and local injection or oral administration of steroids. Preclinical trials are also considered such as adipose tissue stem cell transplantation [36] or cultured cell sheet transplantation [37, 38], but there has been no decisive method so far. Further investigation would be necessary to overcome this problem.
14.6 Outcomes of ESD for Esophageal Squamous Cell Carcinoma
14.6.1 Short-Term Outcomes
Favorable treatment results have been reported from high-volume centers particularly in Japan [24–27]. In short-term outcomes such as a technical feasibility of esophageal ESD, over 90 % of complete resection rate is obtained, whereas the rates of major complications such as delayed bleeding or perforation keep below 2 % in leading centers for ESD. Even if complication occurred, it can be managed conservatively and thus hardly becomes a life-threatening condition. Technically, ESD for the lesion near the esophagogastric junction is sometimes difficult and time-consuming because intraoperative bleeding from abundant collecting vessels occurs frequently. The lesion located in the cervical esophagus, one of natural constrictions, is also difficult to resect because of poor visualization. Furthermore, the risk of aspiration pneumonia becomes extremely high by reflux of fluids (e.g., blood, rinsing water, submucosal fluid). In that case, ESD with general anesthesia should be considered.
Considering the severity of potential postoperative complications, ESD is an apparently less invasive resection method than surgery. However, in case of having severe stricture after extensive resection, multiple balloon dilatation is usually required. Stricture rate after ESD for the lesion involving over three-fourths of the circumference is reported to be 92 % [12].
14.6.2 Long-Term Outcomes
The long-term outcomes of ESD are also favorable. Five-year disease-specific survival rate is almost 100 %. It means that endoscopic local resection is enough for curative resection in esophageal SCC with negligible risk for lymph node metastasis. On the other hand, close surveillance should be conducted for every patient after ESD to detect a metachronous cancer since all of them are regarded as high-risk group. Although there is no reliable evidence regarding an optimal surveillance strategy, endoscopy every 6–12 months is recommended after curative resection in cases of an absolute indication. When a treatment turned to be lateral margin positive or unknown for the absolute indication cases, endoscopy should be performed more closely (e.g., every 3–4 months) to detect local recurrence. In cases of the relative indication cases such as MM or SM1, a CT scan as well as endoscopy every 6–12 months is strongly recommended, if additional treatments (surgery or chemoradiotherapy) are refused after complete local resection.
14.7 Summary
Compared to other treatment options, endoscopic treatment is the most minimally invasive treatment for patients suffering from esophageal cancer with negligible risk for lymph node metastasis. To achieve successful endoscopic treatment, accurate preoperative diagnosis of the lesion, precise control of the endoscope, and adequate knowledge for possible complications are essential [39]. ESD is far better than EMR since reliable margin-free resection is available irrespective of the size or presence of submucosal fibrosis. Therefore, ESD can provide good quality of life to the patient, preserving gastrointestinal function, although it is technically demanding.
References
Ishihara R, Iishi H, Takeuchi Y et al (2008) Local recurrence of large squamous-cell carcinoma of the esophagus after endoscopic resection. Gastrointest Endosc 67:799–804
Ishihara R, Iishi H, Uedo N et al (2008) Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest Endosc 68:1066–1072
Takahashi H, Arimura Y, Masao H et al (2010) Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 72:255–264
Teoh AY, Chiu PW, Yu Ngo DK et al (2010) Outcomes of endoscopic submucosal dissection versus endoscopic mucosal resection in management of superficial squamous esophageal neoplasms outside Japan. J Clin Gastroenterol 44:e190–e194
Japan Esophageal Society (2009) Japanese classification of esophageal cancer, tenth edition: part I. Esophagus 6:1–25
Shimada H, Nabeya Y, Matsubara H et al (2006) Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am J Surg 191:250–254
Eguchi T, Nakanishi Y, Shimoda T et al (2006) Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol 19:475–480
Katada C, Muto M, Momma K et al (2007) Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae - a multicenter retrospective cohort study. Endoscopy 39:779–783
Griffin SM, Burt AD, Jennings NA (2011) Lymph node metastasis in early esophageal adenocarcinoma. Ann Surg 254:731–736
Katada C, Muto M, Manabe T et al (2003) Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions. Gastrointest Endosc 57:165–169
Mizuta H, Nishimori I, Kuratani Y et al (2009) Predictive factors for esophageal stenosis after endoscopic submucosal dissection for superficial esophageal cancer. Dis Esophagus 22:626–631
Ezoe Y, Muto M, Horimatsu T et al (2011) Efficacy of preventive endoscopic balloon dilation for esophageal stricture after endoscopic resection. J Clin Gastroenterol 45:222–227
Takahashi H, Arimura Y, Okahara S et al (2011) Risk of perforation during dilation for esophageal strictures after endoscopic resection in patients with early squamous cell carcinoma. Endoscopy 43:184–189
Suzuki H (2001) Endoscopic mucosal resection using ligating device for early gastric cancer. Gastrointest Endosc Clin N Am 11:511–518
Pouw RE, van Vilsteren FG, Peters FP et al (2011) Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett’s neoplasia. Gastrointest Endosc 74:35–43
Inoue H, Endo M, Takeshita K et al (1992) A new simplified technique of endoscopic esophageal mucosal resection using a cap-fitted panendoscope (EMRC). Surg Endosc 6:264–265
Makuuchi H (1996) Endoscopic mucosal resection for early esophageal cancer – indication and techniques. Dig Endosc 8:175–179
Shimizu Y, Takahashi M, Yoshida T et al (2013) Endoscopic resection (endoscopic mucosal resection/endoscopic submucosal dissection) for superficial esophageal squamous cell carcinoma: current status of various techniques. Dig Endosc 25(Suppl 1):13–19
Yamashita T, Zeniya A, Ishii H et al (2011) Endoscopic mucosal resection using a cap-fitted panendoscope and endoscopic submucosal dissection as optimal endoscopic procedures for superficial esophageal carcinoma. Surg Endosc 25:2541–2546
Urabe Y, Hiyama T, Tanaka S et al (2011) Advantages of endoscopic submucosal dissection versus endoscopic oblique aspiration mucosectomy for superficial esophageal tumors. J Gastroenterol Hepatol 26:275–280
Yahagi N, Uraoka T, Ida Y et al (2011) Endoscopic submucosal dissection using the flex and the dual knives. Tech Gastrointest Endosc 13:74–78
Fukami N, Ryu CB, Said S et al (2011) Prospective, randomized study of conventional versus HybridKnife endoscopic submucosal dissection methods for the esophagus: an animal study. Gastrointest Endosc 73:1246–1253
Ishii N, Horiki N, Itoh T et al (2010) Endoscopic submucosal dissection with a combination of small-caliber-tip transparent hood and flex knife is a safe and effective treatment for superficial esophageal neoplasias. Surg Endosc 24:335–342
Repici A, Hassan C, Carlino A et al (2010) Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series. Gastrointest Endosc 71:715–721
Ono S, Fujishiro M, Niimi K et al (2009) Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 70:860–866
Yamashina T, Ishihara R, Uedo N et al (2012) Safety and curative ability of endoscopic submucosal dissection for superficial esophageal cancers at least 50 mm in diameter. Dig Endosc 24:220–225
Higuchi K, Tanabe S, Azuma M et al (2013) A phase II study of endoscopic submucosal dissection for superficial esophageal neoplasms (KDOG 0901). Gastrointest Endosc 78:704–710
Maeda Y, Hirasawa D, Fujita N et al (2011) Mediastinal emphysema after esophageal endoscopic submucosal dissection: its prevalence and clinical significance. Dig Endosc 23:221–226
Maeda Y, Hirasawa D, Fujita N et al (2012) A pilot study to assess mediastinal emphysema after esophageal endoscopic submucosal dissection with carbon dioxide insufflation. Endoscopy 44:565–571
Nonaka K, Miyazawa M, Ban S et al (2013) Different healing process of esophageal large mucosal defects by endoscopic mucosal dissection between with and without steroid injection in an animal model. BMC Gastroenterol 13:72
Sato H, Inoue H, Kobayashi Y et al (2013) Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone. Gastrointest Endosc 78:250–257
Hashimoto S, Kobayashi M, Takeuchi M et al (2011) The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest Endosc 74:1389–1393
Mizutani T, Tadauchi A, Arinobe M et al (2010) Novel strategy for prevention of esophageal stricture after endoscopic surgery. Hepatogastroenterology 57:1150–1156
Saito Y, Tanaka T, Andoh A et al (2007) Usefulness of biodegradable stents constructed of poly-l-lactic acid monofilaments in patients with benign esophageal stenosis. World J Gastroenterol 13:3977–3980
Takagi R, Murakami D, Kondo M et al (2010) Fabrication of human oral mucosal epithelial cell sheets for treatment of esophageal ulceration by endoscopic submucosal dissection. Gastrointest Endosc 72:1253–1259
Honda M, Hori Y, Nakada A et al (2011) Use of adipose tissue-derived stromal cells for prevention of esophageal stricture after circumferential EMR in a canine model. Gastrointest Endosc 73:777–784
Ohki T, Yamato M, Murakami D et al (2006) Treatment of oesophageal ulcerations using endoscopic transplantation of tissue-engineered autologous oral mucosal epithelial cell sheets in a canine model. Gut 55:1704–1710
Ohki T, Yamato M, Ota M et al (2012) Prevention of esophageal stricture after endoscopic submucosal dissection using tissue-engineered cell sheets. Gastroenterology 143:582–588
Tanaka S, Morita Y, Fujita T et al (2012) Ex vivo pig training model for esophageal endoscopic submucosal dissection (ESD) for endoscopists with experience in gastric ESD. Surg Endosc 26:1579–1586
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Japan
About this chapter
Cite this chapter
Goto, O., Yahagi, N. (2015). Endoscopic Treatment: EMR and ESD. In: Ando, N. (eds) Esophageal Squamous Cell Carcinoma. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54977-2_14
Download citation
DOI: https://doi.org/10.1007/978-4-431-54977-2_14
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54976-5
Online ISBN: 978-4-431-54977-2
eBook Packages: MedicineMedicine (R0)